HY Net Loss Rmb668.0 Million Versus Loss Of Rmb383.1 Million
24/08/2022 15:32
Everest Medicines Ltd 1952.HK :
* EVEREST MEDICINES LTD - HY NET LOSS RMB668.0 MILLION
VERSUS
LOSS OF RMB383.1 MILLION
Source text for Eikon: ID:nHKSbH9cB4
Further company coverage: 1952.HK
Recent news on Everest Medicines
See all newsBrief: Everest Medicines Says NMPA Approves Cardamyst (Etripamil) NDA For PSVT In Adults In China
Brief: Everest Medicines Enters Commercialization Collaboration With Hainan Herui Pharmaceutical
Brief: Everest Medicines Says CBC Group Purchases 712,000 Everest Medicines Shares For Hk$19.2 Million From 16 To 17 June
Australia's Dimerix soars on commercialisation deal with Everest Medicines
Brief: Dimerix Ltd Licenses Dmx200 To Everest For China And Asia Region